NASDAQ: AVIR
Atea Pharmaceuticals Inc Stock Ownership - Who owns Atea Pharmaceuticals?

Insider buying vs selling

Have Atea Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
John VavrickaChief Commercial Officer2025-01-3111,517$3.06
$35.24kSell
Andrea CorcoranChief Financial Officer Executive Vice President Legal and Secretary2025-01-3116,102$3.06
$49.27kSell
Wayne FosterEVP Chief Accounting Officer2025-01-3112,062$3.06
$36.91kSell
Janet Mj HammondChief Development Officer2025-01-3114,134$3.06
$43.25kSell
Maria Arantxa HorgaChief Medical Officer2025-01-3116,071$3.06
$49.18kSell
Jeanpierre SommadossiPresident CEO and Chairman2025-01-3188,601$3.06
$271.12kSell
Franklin M. BergerDirector2025-01-1610,000$3.36
$33.61kBuy
Franklin M. BergerDirector2025-01-1610,000$3.36
$33.61kBuy
Franklin M. BergerDirector2025-01-1515,000$3.19
$47.88kBuy
Franklin M. BergerDirector2025-01-1515,000$3.19
$47.88kBuy

1 of 2

AVIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVIR insiders and whales buy or sell their stock.

AVIR Shareholders

What type of owners hold Atea Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.64%8,990,734$27.33MInstitution
Blackrock Inc 110.64%8,990,734$27.33MInstitution
Bml Capital Management LLC7.87%6,650,000$20.22MInstitution
Fmr LLC7.84%6,618,297$20.12MInstitution
Cormorant Asset Management LP7.59%6,411,355$19.49MInsider
Jeanpierre Sommadossi7.30%6,166,965$18.75MInsider
Andrew A. F. Hack6.65%5,615,659$17.07MInsider
Ecor1 Capital LLC6.44%5,441,896$16.54MInstitution
Vanguard Group Inc5.74%4,851,218$14.75MInstitution
Tang Capital Management LLC5.45%4,607,060$14.01MInstitution

1 of 3

AVIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVIR68.56%25.41%Net SellingNet Selling
HRTX50.53%49.47%Net Selling
ACIU28.24%0.00%
LXRX24.70%75.30%Net Buying
VSTM35.02%64.98%Net SellingNet Selling

Atea Pharmaceuticals Stock Ownership FAQ

Who owns Atea Pharmaceuticals?

Atea Pharmaceuticals (NASDAQ: AVIR) is owned by 68.56% institutional shareholders, 25.41% Atea Pharmaceuticals insiders, and 6.03% retail investors. Cormorant Asset Management LP is the largest individual Atea Pharmaceuticals shareholder, owning 6.41M shares representing 7.59% of the company. Cormorant Asset Management LP's Atea Pharmaceuticals shares are currently valued at $19.17M.

If you're new to stock investing, here's how to buy Atea Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.